Ardehali, S., Rezaei, H. & Nadim, A. 1995. Leishmania and Leishmaniasis Parasites. Tehran University Publishing Center 18-24. (In Persian).
Alizadeh, R., Hooshyar, H., Bandehpor, M., Arbadi, M., Kazemi, F., Talari, A. & Kazemi, B. 2011. Detection of drug resistance gene in cutaneous leishmaniasis by PCR in some endemic areas of iran. Iran Red Crescent Medical Journal 13: 863-867.
Beverley, S.M., Coderre, J.A., Schimke, R.T. & Santi, D.V. 1983. Overproduction of a bifunctional thymidylate synthetase-dihydrofolate reductase and DNA amplification in methotrexate-resistant Leishmania tropica. Proceedings of the National Academy of Sciences of the United States 80: 2132-2136.
Croft, S.L., Seifert, K. & Yardley, V. 2006. Current scenario of drug development for leishmaniasis. Indian Journal of Medical Research 123: 399-410.
Callahan, H.L., Beverley, S.M. 1991. Heavy metal resistance: a new role for P-glycoproteins in Leishmania. Journal of Biological Chemistry 266: 18427-18430.
Chow, L.M., Wong, A.K., Ullman, B. & Wirth, D.F. 1993. Cloning and functional analysis of an extrachromosomally amplified multidrug resistance-like gene in Leishmania enriettii. Molecular Biochemical Parasitology 60: 195-208.
Chao, C.C., Ma, C.M., Cheng, P.W. & Lin-Chao, S. 1990. Increased mdr gene expression and decreased drug accumulation in a human colonic cancer cell line resistant to hydrophobic drug. Biochemical and Biophysical Research Communications 172: 842-849.
Clifton, M.C., Simon, M.J., Erramilli, S.K., Zhang, H., Zaitseva, J., Hermodson, M.A. & Stauffacher, C.V. 2015. In vitro reassembly of the ribose ATP-binding cassette transporter reveals a distinct set of transport complexes. Journal of Biological Chemistry 290: 5555-5565.
Decuypere, S., Yardley, V., De Doncker, S., Laurent T. & Khanal, B. 2005. Gene expression analysis of the mechanism of natural Sb (v) resistance in Leishmania donovani isolates from Nepal Antimicrobial Agents and Chemotherapy 49: 4616-4621.
Ellenberger, T.E., Beverley, S.M. 1989. Multiple drug resistance and conservative amplification of the H region in Leishmania major. Journal of Biological Chemistry 264: 15094-15103.
Ellenberger, T.E., Beverley, S.M. 1989. Multiple drug resistance and conservative amplification of the H region in Leishmania major. Journal of Biological Chemistry 264: 15094-15103.
Ferreira-Pinto, K.C., Miranda-Vilela, A.L., Anacleto, C., Fernandes, A.P., Abdo, MC., Petrillo-Peixoto, M.L. & Moreira, E.S. 1996. Leishmania guyanensis: isolation and characterization of glucantim resistance cell lines. Canadian Journal of Microbiology 42: 944-949.
Gokirmak, T., Campanale, J.P., Shipp, L.E., Moy, G.W., Tao, H. & Hamdoun, A. 2012. Localization and substrate selectivity of sea urchin multidrug (MDR) efflux transporters. Journal of Biological Chemistry 287: 43876-43883.
Hadighi, R., Mohebali, M., Boucher, P., Hajjaran, H., Khamesipour, A. & Ouellette, M. 2006. Unresponsiveness to Glucantime treatment in Iranian Cutaneous leishmaniasis due to drug resistant Leishmania tropica parasites. PLOS Medicine 3: 162-168.
Haimeur, A., Guimond, C., Pilote, S., Mukhopadhyay, R., Rosen, B.P., Poulin, R. & Ouellette, M. 2011. Elevated levels of polyamines and trypanothione resulting from over expression of the ornithine decarboxylase gene in arsenite-resistant Leishmania. Molecular Microbiology 34: 726-735.
Henderson, D.M., Sifri, C.D., Rodgers, M., Wirth, D.F., Hendrickson, N. & Ullman, B. 1992. Multidrug resistance in Leishmania donovani is conferred by amplification of a gene homologous to the mammalian mdr1 gene. Molecular and Cellular Biology 12: 2855-2865.
Higgins, C.F. 1992. ABC transporters: from microorganisms to man. Annual Review of Cell Biology 8: 67-113.
Hoffmeyer, S., Arnold, H.P., Brockmoller, J. & Johne, A. 2000. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proceedings of the National Academy of Sciences 97: 3473-3478.
Juliano, R. L., Ling, V. 1976. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochimica et Biophysica Acta (BBA) – Biomembranes 455: 152-162.
Katakura, K., Iwanami, M., Ohtomo, H., Fujise, H. & Hashiguchi, Y. 1999. Structural and functional analysis of the LaMDR1 multidrug resistance gene in Leishmania amazonensis. Biochemical and Biophysical Research Communications 255: 289-294.
Legare, D., Richard, D., Mukhopadhyay, R., Stierhof, Y.D., Rosen, B.P. & Haimeur, A. 2001. The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase. Journal of Biological Chemistry 276: 26301-26307.
Mohebali, M., Yaghoobi, P., Hooshmand, B. & Khamesipour, A. 2004. Efficacy of Paromomycin ointment prepared in Iran (Paromo-U) against cutaneous Leishmaniasis caused by Leishmania major in mouse model. Iranian Journal of Dermatology 88-94. (In Persian).
Ouellete, M., Fase-Fower, F., Borst, P. 1990. The amplified H circle of methotrexate-resistant Leishmania tarentolae contains a novel p-glycoprotein gene. European Molecular Biology Organization Journal 9: 1027-1033.
Piscopo, T.V. & Mallia, A.C. 2006. Leishmaniasis. Postgraduate Medical Journal 82: 649-657.
Polat, E. & Kutlubay, Z. 2014. Four cutaneous leishmaniosis case resistant to meglumineantimoniate treatment. Turkish Parasitol Derg 38: 177-180.
Sundar, S., More, D.K., Singh, M.K., Singh, V.P., Sharma, S., Makharia, A., Kumar, P.C. & Murray, H.W. 2000. Failure of pentavalent antimony in Visceral leishmaniasis in India: report from the center of the Indian epidemic. Clinical Infectious Diseases 31: 1104-1107.
Sundar, S., Chakravarty, J. 2014. An update on pharmacotherapy for leishmaniasis. Expert Opinion on Pharmacotherapy 16: 237-252.
Vincent, I.M. & Barrett, M.P. 2015. Metabolomic-Based Strategies for Anti-Parasite Drug Discovery. Journal of Biomolecular Screening 20: 44-55.